Clearview – Rapid Solutions for Detecting Malaria

The Clearview® Malaria rapid test range from Inverness Medical provides a complete, rapid diagnostic solution for in vitro detection of malarial antigens in whole blood. This simple and easy to use test is available in two different formats: Clearview® Malaria P.f. is a qualitative test for detecting the most common, virulent and deadly malaria causing parasite, Plasmodium falciparum; Clearview® Malaria Combo detects and differentiates between the Plasmodium falciparum, P. vivax, P. malariae and P. ovale antigens.

Both of these rapid tests detect antigens from capillary or venous whole blood and provide easy to interpret results in just 15 minutes. Malaria is a parasitic disease spread via Anopheles mosquitoes, and can cause severe flu-like symptoms. With an estimated 1 – 2 million deaths each year attributed to malaria (ref. RDT Info), morbidity, mortality, and transmission can be significantly reduced if infection is accurately diagnosed and effectively treated.

Ideal for remote health centres, the Clearview Malaria rapid test range is manufactured to meet the harsh conditions of malaria endemic regions. The tests can withstand high temperatures, no refrigeration, and require little training for accurate use. As such, these rapid diagnostic tests play a pivotal role in the Roll Back Malaria Partnership’s Global Malaria Action Plan, where quick diagnosis of the correct malarial strain will enable fast initiation of the correct treatment. Furthermore, the rapid spread of anti-malarial drug resistance will be minimised, as treatment can be highly targeted and controlled.